Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer

Abstract Objective To compare Prostate Health Index (PHI) and prostate‐specific antigen (PSA) density as secondary tests after multiparametric magnetic resonance imaging (mpMRI) in improving the detection accuracy of Gleason grade group (GG) 2‐5 prostate cancer (PCa) and in decreasing unnecessary bi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Samuel Carbunaru, James Stinson, Rilwan Babajide, Courtney M. P. Hollowell, Ximing Yang, Marin Sekosan, Karen Ferrer, Andre Kajdacsy‐Balla, Josephine Abelleira, Maria Ruden, Patrice King‐Lee, Daniel P. Dalton, David D. Casalino, Rick A. Kittles, Peter H. Gann, Edward M. Schaeffer, Adam B. Murphy
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	African American biomarker cancer detection PIRADS 3 Prostate Health Index prostate MRI Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/26a1353c71a044758901967680e4da82
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer

Ejemplares similares